Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
Li Zhang, Zhehai Wang, Jian Fang, Qitao Yu, Baohui Han, Shundong Cang, Gongyan Chen, Xiaodong Mei, Zhixiong Yang, Victoria Jennifer Stefaniak, Yong Lin, Shuyan Wang, Wen Zhang, Luyao Sun, Yunpeng Yang
Topics & Concepts
PemetrexedMedicineOncologyInternal medicineOverall survivalChemotherapyCisplatinLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment